Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000667947 | SCV000792476 | likely pathogenic | Argininosuccinate lyase deficiency | 2017-06-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000667947 | SCV003440057 | pathogenic | Argininosuccinate lyase deficiency | 2022-12-23 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 552651). This premature translational stop signal has been observed in individual(s) with Argininosuccinate lyase deficiency (PMID: 24166829). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Trp245*) in the ASL gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ASL are known to be pathogenic (PMID: 2263616, 24166829). |
Baylor Genetics | RCV000667947 | SCV004201228 | pathogenic | Argininosuccinate lyase deficiency | 2023-11-30 | criteria provided, single submitter | clinical testing |